IRB Check Up: Pediatric Consent Forms Generally Robust, FDA Finds
This article was originally published in The Pink Sheet Daily
Survey results are a salve for industry and agency alike, but patient advocates still press for refinements during an FDA workshop.
You may also be interested in...
Quality has moved up in importance as a criterion for selecting an institutional review board following an April 14 FDA warning letter to Coast IRB and the company's agreement to halt enrollment in clinical studies it monitors
HHS Secretary's Advisory Committee on Human Research Protections Chairman Prentice argues that the nation's network of IRBs may be inconsistent in their protection of human research subjects, but it is not as broken as many would portray it. "It's never going to be a perfect system," Prentice says.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.